Cargando…

Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis

We investigated acute effects of intermittent large dose bisphophonate therapy in osteoporotic patients. Peripheral blood mononuclear cells were incubated with alendronate (100 µM) for 18 hr, in vitro and cytokine expressions were measured by real-time RT-PCR. Pamidronate 30 mg was administered on 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Mie Jin, Kwon, Seong Ryul, Park, Shin-Goo, Park, Won
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923784/ https://www.ncbi.nlm.nih.gov/pubmed/20808669 http://dx.doi.org/10.3346/jkms.2010.25.9.1277

Ejemplares similares

The Author Response: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Park, Won
Publicado: (2011)

Letter to the Editor: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Marcuzzi, Annalisa, et al.
Publicado: (2011)

Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents
por: Yoon, Ji-Hee, et al.
Publicado: (2021)

Intravenous Pamidronate for Refractory Lymphedema
por: Beigi, A A, et al.
Publicado: (2011)

Intravenous pamidronate for refractory rheumatoid arthritis
por: Salesi, Mansour, et al.
Publicado: (2012)

Effectiveness of the treatment with intravenous pamidronate in children with rheumatic diseases
por: Marco, A, et al.
Publicado: (2008)

A Comparison of Three Different Guidelines for Osteoporosis Treatment in Patients with Rheumatoid Arthritis in Korea
por: Yoon, Jiyeol, et al.
Publicado: (2010)

Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use
por: Lim, Mie Jin, et al.
Publicado: (2014)

Effect of cyclic pamidronate administration on osteoporosis in children with β-thalassemia major: a single-center study
por: El-Hawy, Mahmoud A., et al.
Publicado: (2022)

Digital Thermography of the Fingers and Toes in Raynaud's Phenomenon
por: Lim, Mie Jin, et al.
Publicado: (2014)

High-dose intravenous pamidronate for metastatic bone pain.
por: Purohit, O. P., et al.
Publicado: (1994)

Treatment of Polyostotic Fibrous Dysplasia of the Thoracic Spine with Intravenous Pamidronate: Result from 9 Months Follow Up
por: Lee, Jongjoo, et al.
Publicado: (2015)

The Neurological Safety of Epidural Pamidronate in Rats
por: Lee, Pyung Bok, et al.
Publicado: (2010)

Inflammation is responsible for systemic bone loss in patients with seropositive rheumatoid arthritis treated with rituximab
por: Lim, Mie Jin, et al.
Publicado: (2023)

Short-term Efficacy of Monthly Pamidronate Infusion in Patients with Osteogenesis Imperfecta
por: Choi, Jin-Ho, et al.
Publicado: (2007)

Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats
por: Pereira, F.A., et al.
Publicado: (2012)

Prevention of Comorbidity and Acute Attack of Gout by Uric Acid Lowering Therapy
por: Joo, Kowoon, et al.
Publicado: (2014)

Serum Procalcitonin for Differentiating Bacterial Infection from Disease Flares in Patients with Autoimmune Diseases
por: Joo, Kowoon, et al.
Publicado: (2011)

Effects of pamidronate administration on tooth eruption and mandibular growth in new born rats
por: Tuncer, Ibrahim, et al.
Publicado: (2017)

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
por: Purohit, O. P., et al.
Publicado: (1995)

Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD).
por: Ling, P. J., et al.
Publicado: (1995)

Pamidronate therapy for hypercalcemia of childhood malignancy
por: Sng, Andrew, et al.
Publicado: (2015)

Palisaded Neutrophilic Granulomatous Dermatitis in a Patient with Systemic Sclerosis-Rheumatoid Arthritis Overlap Syndrome
por: Jung, Kyong-Hee, et al.
Publicado: (2017)

ODP094 Hypercalcemia caused by Mycobacterium Avium Complex, with Excellent Response to Intravenous Pamidronate.
por: Khthir, Rodhan
Publicado: (2022)

Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density
por: Lim, Se Won, et al.
Publicado: (2016)

Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates
por: Eekman, Danielle A, et al.
Publicado: (2009)

Metabolic effects of pamidronate in patients with metastatic bone disease.
por: Vinholes, J., et al.
Publicado: (1996)

Acute Pancreatitis Occurring after Pamidronate Infusions in Two Patients with Spondyloarthritis
por: Toussirot, Éric, et al.
Publicado: (2013)

Therapy with pamidronate in children with osteogenesis imperfecta
por: Marginean, Otilia, et al.
Publicado: (2017)

Effects of Adding Intravenous Pamidronate to Ongoing Menopausal Hormone Therapy in Postmenopausal Korean Women with Low Bone Mineral Density
por: Koo, Young-Ah, et al.
Publicado: (2019)

Effects of Pamidronate Disodium Combined with Calcium on BMD Values and Severity of Pain in Elderly Patients with Osteoporosis Based on Mobile Terminal Platform for Internet of Things
por: Bai, Zuoming, et al.
Publicado: (2022)

Extensive Thrombosis in a Patient with Familial Mediterranean Fever, Despite Hyperimmunoglobulin D State in Serum - First Adult Case in Korea
por: Joo, Kowoon, et al.
Publicado: (2013)

Height and weight development following cyclical intravenous pamidronate in children and adolescents with chronic recurrent multifocal osteomyelitis (CRMO)
por: Miettunen, PM, et al.
Publicado: (2008)

Pamidronate “zebra lines”: A treatment timeline
por: Loizidou, Avgi, et al.
Publicado: (2017)

Pamidronate Treatment of Osteonecrosis of the Hip in Young Male
por: Lo Gullo, A., et al.
Publicado: (2018)

Inhibition of growth and migration of cholangiocarcinoma cells by pamidronate
por: Buranrat, Benjaporn, et al.
Publicado: (2019)

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial
por: von Au, Alexandra, et al.
Publicado: (2016)

The effect of pamidronate delivery in bisphosphonate-naïve patients on neutrophil chemotaxis and oxidative burst
por: Chadwick, Jeffrey W., et al.
Publicado: (2020)

Pamidronate Down-regulates Tumor Necrosis Factor-alpha Induced Matrix Metalloproteinases Expression in Human Intervertebral Disc Cells
por: Kang, Young-Mi, et al.
Publicado: (2016)

Erratum: Correction of Title
por: Joo, Kowoon, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_50ufmbih46r32dqiv9ohph5mmu